Dr. Jane Wachira’s KEVEVAPI Exposed As Contaminated Vaccines And Unauthorized Sales Revealed

Dr. Jane Wachira, as the Chief Executive Officer of the Kenya Veterinary Vaccines Production Institute (KEVEVAPI), has been at the center of several controversies that have raised serious concerns about her leadership and the institute’s operations.

One issue involves allegations of selling foot-and-mouth disease vaccines to unauthorized entities. Dr. Wachira has faced accusations of distributing these vaccines to MTK, a company purportedly lacking the necessary authorization.

In response, she has denied these claims, asserting that any documentation presented by MTK is fraudulent.

Additionally, KEVEVAPI has been under scrutiny following reports of contaminated animal vaccines.

The African Union Pan African Vaccines Center initiated a probe into the institute after an AU report (referenced QCR 849) highlighted unacceptably high levels of contamination, rendering KEVEVAPI’s products unsafe for animal use.

This situation has led to a loss of confidence among stakeholders and questions about the institute’s quality control measures.

The Kenya Veterinary Association (KVA) has expressed doubts about the government’s ability to conduct an effective nationwide livestock vaccination exercise, citing public distrust and inadequate public sensitization.

The association has called for a halt to the exercise, emphasizing the need for rigorous communication and adequate funding for veterinary services.

These controversies have cast a shadow over Dr. Wachira’s tenure at KEVEVAPI, raising questions about her leadership and the institute’s commitment to maintaining high standards in vaccine production and distribution.

The allegations of unauthorized vaccine sales, contamination issues, and public distrust in vaccination programs suggest systemic problems that require immediate attention.